Sort by
Refine Your Search
-
will establish and lead an internationally recognized research program focused on the identification, design, synthesis, and optimization of novel small molecule therapeutics. Applications are
-
optimization of quantum algorithms for hybrid quantum simulators. Applicants should have a PhD in Physics, Chemistry, Computer Science, or a closely related field. To apply, a CV, a brief statement of
-
optimization of quantum algorithms for hybrid quantum simulators. Applicants should have a PhD in Physics, Chemistry, Computer Science, or a closely related field. To apply, a CV, a brief statement of
-
optimization of quantum algorithms for hybrid quantum simulators. Applicants should have a PhD in Physics, Chemistry, Computer Science, or a closely related field. To apply, a CV, a brief statement of
-
optimization of quantum algorithms for hybrid quantum simulators. Applicants should have a PhD in Physics, Chemistry, Computer Science, or a closely related field. To apply, a CV, a brief statement of
-
optimization of imaging systems, contribute to research studies, maintain laboratory operations, and support ongoing scientific initiatives within the laboratory. Interested applicants should submit a CV
-
mechanistic discovery with therapeutic innovation. The successful candidate will develop advanced computational and systems-level frameworks to interrogate putative therapeutic compounds for optimization to
-
(experimentalist only). The project focuses on experimental design, optimization, and construction of entangled and/or squeezed states of light for a range of applications. The role also involves building and
-
design and optimization of conformational B-cell epitopes Combination immunotherapy with chemotherapy, targeted therapies, and immune checkpoint modulation Translation of peptide vaccines from preclinical
-
design and optimization of conformational B-cell epitopes Combination immunotherapy with chemotherapy, targeted therapies, and immune checkpoint modulation Translation of peptide vaccines from preclinical